Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole Oral Acceptability Trial

NCT00101569 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Development & Commercialization, Inc. as lead sponsor.

NCT NCT00101569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00101569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole Oral Acceptability Trial
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2004
Completion date
March 31, 2005
Enrollment
59
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia